Abstract
This article summarizes the clinical utility of PSA both as pretreatment prognostic factor and as an invaluable post-treatment marker. Some pathobiologic correlations between serum PSA kinetics and putative tumor cell kinetic mechanisms are discussed.
Original language | English (US) |
---|---|
Pages (from-to) | 737-747 |
Number of pages | 11 |
Journal | Urologic Clinics of North America |
Volume | 20 |
Issue number | 4 |
State | Published - 1993 |
ASJC Scopus subject areas
- Urology